You are here
XBB COVID vaccine estimated effective rate: 63% to 68% against more severe illness in kids
Primary tabs
XBB COVID vaccine estimated effective rate: 63% to 68% against more severe illness in kids
Fri, 2024-12-13 23:41 — mike kraft XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids The adjusted effectiveness of the updated Pfizer/BioNTech COVID-19 XBB vaccine in the 2023-24 US respiratory virus season was 68% and 63% against hospitalization or emergency department (ED) or urgent-care visits among children aged 5 to 11 years and 12 to 17 years, respectively, with an overall effectiveness for both age-groups of 65%, a Kaiser Permanente Southern California (KPSC)-led research team estimates. CIDRAP
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments